WO2016079654A1 - Method for score confidence interval estimation when vital sign sampling frequency is limited - Google Patents
Method for score confidence interval estimation when vital sign sampling frequency is limited Download PDFInfo
- Publication number
- WO2016079654A1 WO2016079654A1 PCT/IB2015/058847 IB2015058847W WO2016079654A1 WO 2016079654 A1 WO2016079654 A1 WO 2016079654A1 IB 2015058847 W IB2015058847 W IB 2015058847W WO 2016079654 A1 WO2016079654 A1 WO 2016079654A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patient
- confidence interval
- current time
- score
- status value
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7221—Determining signal validity, reliability or quality
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
Definitions
- the following relates generally to the medical monitoring arts, medical warning systems concerning a monitored patient, and so forth.
- EWS early warning scoring
- ICU intensive care unit
- CCU cardiac care unit
- MEWS Modified Early Warning System
- each of these physiological parameters has a normal range with score zero, and the score component for the physiological parameter increases as the value moves further out of the normal range.
- the scores for the physiological parameters are totaled, and a score greater than a threshold, e.g. 5, is considered an action trigger (for example, triggering an emergency medical team call, triggering transfer to ICU or CCU, et cetera).
- EWS systems have been paper-based systems.
- the nurse suitably fills in parameter scores on a printed table, and adds the values together to produce the EWS score.
- a patient monitoring system including a display device; and an electronic data processing component programmed to perform a patient monitoring method including, at each successive current time: determining a patient status value at the current time based a most recently received measurement for each of one or more input physiological parameters; estimating a confidence interval for the patient status value at the current time based on a time interval between the current time and a receipt time of the most recently received measurement for each of the one or more input physiological parameters; and displaying patient status information on the display device wherein the displayed patient status information is based on both the patient status value at the current time and the estimated confidence interval for the patient status value at the current time.
- the patient status value may be an early warning system (EWS) score and the determining may comprise computing the EWS score based on the most recently received measurements of a plurality of input physiological parameters. In some embodiments the EWS score assumes only integer values.
- the patient status value at the current time together with the estimated confidence interval for the patient status value at the current time may be displayed on the display device.
- the estimating may comprise: estimating a confidence interval at the current time for each input physiological parameter based on the time interval between the current time and the receipt time of the most recently received measurement for the input physiological parameter; and estimating the confidence interval for the patient status value at the current time based on the estimated confidence intervals at the current time for the plurality of input physiological parameters.
- the confidence interval is estimated based on a statistical distribution of measurements for the input physiological parameter(s) stored in a past patients database.
- a most stale parameter may be determined as the parameter of the plurality of parameters that most contributes to the confidence interval for the patient status value.
- the most stale parameter may be displayed on the display, for example in the form of a recommendation to update (that is, remeasure) the most stale parameter.
- a patient monitoring system includes a display device, and an electronic data processing component programmed to perform a patient monitoring method including: receiving measurements of physiological parameters; and at each successive current time: (i) computing an early warning system (EWS) score based on the most recently received measurements of physiological parameters, (ii) estimating a confidence interval for the EWS score based on time intervals between the current time and receipt times of the most recently received measurements of physiological parameters, and (iii) displaying EWS information on the display device (10) wherein the displayed EWS information is based on both the computed EWS score and the estimated confidence interval for the EWS score.
- the displayed EWS information may include the computed EWS score and the estimated confidence interval for the EWS score.
- a method comprises: determining a patient status value at a current time based a most recently received measurement for each of one or more input physiological parameters; estimating a confidence interval for the patient status value at the current time based on a time interval between the current time and a receipt time of the most recently received measurement for each of the one or more input physiological parameters; and displaying patient status information on a display device.
- the displayed patient status information is based on both the patient status value at the current time and the estimated confidence interval for the patient status value at the current time.
- One advantage resides in improving effectiveness and accuracy of a patient monitor in conveying a patient's risk.
- Another advantage resides in better allocation of hospital resources. For example, resources may be allocated to patients who are more at risk.
- Another advantage resides in providing a patient monitor capable of recommending physiological parameter measurements, such as in order to facilitate patient risk assessment.
- the invention may take form in various components and arrangements of components, and in various steps and arrangements of steps.
- the drawings are only for purposes of illustrating the preferred embodiments and are not to be construed as limiting the invention.
- FIGURE 1 diagrammatically shows an embodiment of a patient monitoring system.
- FIGURE 2 shows an error distribution for a heart rate.
- FIGURE 3A shows an example of a single-parameter alarm system.
- FIGURE 3B shows an example of an analytical calculation of a new score in a multi-parameter discrete scoring system.
- FIGURE 4 shows a score distribution of early deterioration indicator (EDI) when the most recent score is in a particular range.
- EDI early deterioration indicator
- FIGURE 5 diagrammatically shows a process related to the probability of a score exceeding a threshold.
- FIGURE 6 shows an example where an EDI is calculated based on heart rate
- HR ambulatory blood pressure
- ABSP ambulatory blood pressure
- FIGURE 7 shows an example where an EDI is calculated based on HR, temperature and ABP.
- Patients are commonly monitored by an electronic patient monitor that receives multiple physiological parameter inputs, such as heart rate (HR), blood pressure, and/or respiration rate (RR), and plots trends and/or displays instantaneous values for each parameter. It may be advantageous for such a patient monitor to also compute and display an Early Warning System (EWS) score that provides an indication of whether patient condition may be degrading sufficiently to call for remedial action.
- EWS Early Warning System
- the EWS score can be computed based on monitored values acquired by the patient monitor, possibly along with values of other parameters entered by the nurse or read from the Electronic Medical Record (EMR).
- EMR Electronic Medical Record
- the patient monitor may continuously monitor the heart rate, blood pressure, and respiration rate (possibly along with other parameters such as Sp0 2 ).
- a difficulty recognized herein is that such a display can be misleading because medical personnel may misunderstand the displayed EWS score as being an accurate real-time value.
- the "ground truth" EWS score can change from moment to moment as the patient condition improves or worsens, while the EWS score displayed on the patient monitor only reflects the last measurement of each input physiological parameter.
- the displayed EWS score may be up to one hour out of date due to reliance on an "old" temperature measurement.
- alertness is only measured twice per day, then the displayed EWS score may be based on an alertness score that is up to 12 hours old. If different physiological parameters are measured at different times, the displayed EWS score may never be completely current.
- the patient monitor provides an EWS score that appears to be a real-time value, but which in fact may be out of date due to various changes in the patient that have occurred since the last patient measurement(s).
- a further problem exists in that, even if medical personnel recognize the EWS score may be out of date, it is not readily apparent how to improve the EWS score accuracy.
- false negatives can occur, in which the (outdated) EWS score indicates the patient is stable when in actuality the patient's condition has deteriorated to a point at which action may be called for.
- a patient's condition is dynamic over time.
- displaying such a "false negative" score may give clinicians false impression that the patient's condition is stable.
- medical personnel may also be informed of which parameter(s) are advantageously updated (e.g. remeasured) in order to efficiently reduce the uncertainty.
- This technology is suitably offered as part of a patient monitoring system.
- One embodiment includes the following operations: (1) generate statistical distribution of parameters/scores by retrospectively analyzing past patient data, (2) at a given time from last measurement, estimate the confidence interval for the actual score, and (3) display probable scores or alarms with their probability values. With this approach, a range of scores can describe a patient's current status more accurately even though only old measurements are available.
- confidence interval in statistics generally refers to a statistical estimation of a range within which a parameter falls within a population. For example, a 95% confidence interval for a parameter indicates that, for a population of statistically significant size, 95% of the members of the population will exhibit a value for the parameter falling within the 95% confidence interval.
- the term "confidence interval” is intended to encompass uncertainty metrics that are explicitly expressed as confidence intervals, as well as uncertainty metrics expressed using other formalisms such as margin of error (for example, a confidence interval may be expressed as a margin of error, e.g. the parameter is known with a +5% margin of error).
- the directly measured physiological data may be ECG electrode voltages, and the patient monitor 20 then processes these data by computing lead voltages (differential voltages between selected electrodes) and/or by computing a heart rate based on signal periodicity.
- the patient monitor 20 may display the ECG lead traces as monitored physiological parameters, and/or may display the heart rate as a trend and/or as a current numeric value.
- the illustrative sensors 8 are in wired connection with the patient monitor 20, but sensors may additionally or alternatively be connected wirelessly, e.g. by a Bluetooth or Zigbee protocol wireless link, an infrared link, or so forth.
- the various physiological parameters obtained from the physiological sensors 8 are suitably displayed on the display device 10 as traces (that is, values plotted as a function of time) and/or as current numerical values.
- the patient monitor 20 may be variously configurable, for example enabling user selection of which parameters to display, the display format (numeric value, trace, or both), setting upper and/or lower alarm limits for various parameters, or so forth.
- the patient monitor 20 further includes one or more user input devices such as a keyboard (possibly implemented as an LCD keyboard or a touch-sensitive area of the display), via which a nurse may enter values for one or more parameters that are not measured by the sensors 8 but rather measured by the nurse (for example, an alertness score, a manually acquired patient temperature reading, et cetera).
- the patient monitor 20 is connected with an electronic data network (e.g. a hospital network and/or the Internet), and in such embodiments the patient monitor 20 may receive measurements for one or more patient physiological parameters over the network (for example, hematology laboratory results).
- the patient monitor 20 or other computational device also computes confidence intervals for one or more physiological parameters, and/or for an EWS score or other derived parameter (generally, a patient status value), and displays patient status information on the display device 10 that is based on both the patient status value at the current time and the estimated confidence interval for the patient status value at the current time.
- the patient monitor 20 or other computational device may, for example: receive at least one parameter of a patient (step 101), read an error distribution derived offline from past patent's data (or in an alternative approach calculate an error distribution online from current patient's data) (step 102), and display the error distribution and confidence interval (step 103).
- the first illustrative embodiment pertains to score estimation for single- parameter alarms or discrete scoring models.
- Generation of the distribution for individual parameters can be performed as follows, where it is assumed that at time to, a vital sign is measured and the value is v 0 .
- the terms "physiological parameter” and “vital sign” are used interchangeably herein.)
- v' the actual value of the parameter at this moment
- ⁇ the error caused by using the old measurement
- ⁇ ⁇ '- ⁇
- the actual values of v' and ⁇ is not known, but the probability of v' and ⁇ can be estimated by retrospectively analyzing past patient data as follows.
- the x axis is the time delay At
- the y axis is the error ⁇
- the z axis is the probability of error. It is seen that using measurements taken hours ago causes significant uncertainty. In general, the magnitude of error increases as the time ⁇ since the last measurement increases.
- Score or alarm confidence interval estimation can be performed as follows. In general, an alarm can be triggered by a single-parameter or a multi-parameter score exceeding a certain threshold or thresholds.
- a parameter e.g., HR
- v 0 The probability of a single-parameter alarm based on HR exceeding a threshold at a later time t' is:
- most recent measure taken At ago) where the probability can be obtained from the error distribution as described above.
- the probability could be obtained from the error distribution shown in FIGURE 2.
- the probability of a multi-parameter score exceeding a certain threshold can be analytically calculated.
- MEWS Modified Early Warning System
- a situation is deemed to call for immediate attention when the MEWS score indicates the patient is on the edge of deterioration.
- a score 5 is taken as the critical threshold in some MEWS implementations.
- the MEWS score at time to is denoted here as MEWS 0 .
- MEWS 0 4. If, as time progresses forward from to, the probability of the actual score being 5 becomes high due to the confidence interval increasing with time since the last measurement, a notification can be issued to advise a new measurement reading to improve score confidence.
- the probability of the actual score being 5 can, for example, be analytically calculated by:
- the confidence interval as a function of time since to is, in some embodiments, suitably characterized by statistical analysis of patient data in a past patients database as described for example with reference to FIGURE 2. Additionally or alternatively, the confidence interval may be estimated based on past data for the current patient 6 undergoing current monitoring. For example, the statistical analysis described with reference to FIGURE 2 can be applied to past acquired data for the current patient 6. This approach accounts for historical variability of parameters for the current patient 6. For example, if the HR for the current patient 6 has been steady at about 70 bpm in the past and has not gone above 80 bmp or below 65 bpm, then the interval [65,80] bpm may be a reasonable confidence interval for the HR.
- remediation additionally or alternatively includes informing medical personnel of which physiological parameter measurement is most stale.
- the most stale parameter is the parameter that most contributes to the uncertainty of the EWS score.
- the patient monitor 20 can display a message on the display device 10 indicating the stale parameter and recommending obtaining a new measurement of the stale parameter.
- the patient monitor 20 can display a message on the display device 10 indicating the stale parameter and recommending obtaining a new measurement of the stale parameter.
- the probability of the actual score exceeding higher decisionmaking thresholds, or other information based on the calculated confidence interval can be displayed. Recommendations can be provided, such as additional spot check to confirm if the actual score is in a dangerous zone.
- FIGURE 3 further illustrates various aspects.
- the first step is to estimate the error distribution caused by using old measurements. This corresponds to FIGURE 2.
- the second step is to calculate the confidence interval for the vital sign at time t>to and the probability that the vital sign exceeds a certain threshold for t>t 0 .
- the "certain threshold” may be a threshold for taking some remedial action such as administering a medication or calling the on-call physician.
- the confidence interval can be displayed with the score and notifications can be sent when the probability of exceeding the certain threshold is high.
- the first step is to estimate the error distribution of each physiological parameter.
- the second step is to calculate the probability of the actual score exceeding the next decision-making threshold (e.g., actual MEWS equals 5 while the score calculated from the most recent measurement is 4).
- the last step is to display the probability with the score.
- FIGURE 3B shows a diagrammatic example of the display. The solid lines extending horizontally from to and ti are the MEWS score calculated based on the most recent measurements. All parameters used to compute the MEWS score are measured at time to, and again at time ti, and again at time t 2 .
- the MEWS scores at times to, ti, and t 2 are considered exact (within the measurement accuracy), and the confidence interval is zero at times to, ti, and t 2 .
- the dotted line extending from to plots the probability of the actual score exceeding the decision-making threshold. The probability increases with time until new measurements are available at ti.
- the patient status information that is displayed along with estimated confidence interval information comprises MEWS scores, which is a discrete valued quantity as it only assumes integer values.
- MEWS scores which is a discrete valued quantity as it only assumes integer values.
- EDI early deterioration indicator
- This is a continuous valued parameter, rather than a discrete valued parameter as in MEWS.
- the analytical calculation described previously may still be used but is computationally intensive.
- the confidence interval of scores can be estimated by a method similar to the above mentioned single-parameter alarm scenario.
- the x axis is the time delay At
- the y axis is the actual score s'
- the color indicates the probability of the actual score.
- the uncertainty of the EDI score at a given time t separated by a delay At from the time to of the last set of measurements can be estimated from this calibration data.
- the EDI score confidence interval estimation can then be performed as follows. Assume the score at to is so- The probability of the actual score at a later time t' is: p (EDI' I most recent EDI taken At ago) where the probability p can be obtained, for example, from step 1 of either FIGURE 3A or 3B.
- the process includes two phases: (1) a confidence interval distribution generation phase (steps 501, 502); and (2) a patient monitoring phase (steps 503, 504, 505, 506) during which the current patient 6 is monitored.
- a database of physiological parameters for past patients is provided. This may comprise a log of measurements stored in memory of the patient monitor 20, and/or may comprise logs of measurements accrued from a plurality of patient monitors, for example used throughout the Intensive Care Unit or other medical facility.
- the physiological measurements from the database are used to generate or estimate the distribution of actual score as a function of (i) the most recently generated score and (ii) the time interval At since last set of measurements used to generate that most recent score.
- the confidence interval distribution is generated.
- the monitoring phase is performed, in which the current patient 6 is monitored.
- the EDI is measured and the confidence interval is set to zero (or to some small value indicative of the measurement uncertainty).
- the EDI score remains set to the EDI score measured at to, but a confidence interval is estimated from the confidence interval distribution (e.g. step 504 of FIGURE 5) using the EDI score at to and the time interval since to as inputs.
- FIGURE 6 shows a diagrammatic example of the display where the uncertainty range (i.e. confidence interval) of the EDI score is calculated based only on HR and ABP.
- the dotted line corresponding to HR demonstrates that HR is measured frequently enough to approximate continuous measurement, and so HR does not contribute to the uncertainty of the EDI.
- ABP is measured only at to, ti and t 2 .
- the EDI score is exactly known only at the point when all of the parameters are known (e.g. at to, ti, and t 2 the confidence interval is zero).
- the EDI score uncertainty increases and range of EDI may be estimated by retrospectively analyzing past patient data, as discussed above.
- FIGURE 6 diagrammatically shows linear symmetrical increases above/below the EDI score at to, this does not have to be the case.
- the changes do not have to be linear, or symmetrical in the plus/minus directions.
- FIGURE 7 shows another diagrammatic example of the display.
- the EDI uncertainty range is calculated based on ABP, HR and temperature. Similar to FIGURE 6, the dotted line corresponding to HR illustrates that HR is measured frequently enough to approximate a continuous measurement.
- temperature is measured only at times to and t 3
- ABP is measured only at times to, ti and t 2 . It is noted that these times do not coincide in this example - that is, the ABP and temperature are not measured at the same time, but rather at different times. Thus, except at to, there is no point in time at which all physiological parameters contributing to the EDI score are simultaneously measured.
- the range of EDI may be estimated by retrospectively analyzing past patient data, as discussed above. Because, in the example of FIGURE 7, the parameters are only all known at to, the confidence interval is only zero at to— the confidence interval is not zero at ti, t 2 , and t 3 .
- FIGURE 7 demonstrates that, in a multi -parameter system, measuring one physiological parameter contributing to the EWS score at a given time may not be enough to make the score known with absolute certainty, since other parameters contributing to the EWS score may be "old" and hence uncertain.
- the measurement of a parameter contributing to the uncertainty does reduce the uncertainty, as seen by the abrupt reduction in confidence interval after each measurement (that is, at ti, t 2 , t 3 ). That is, the measurement does still lead to knowing the (illustrative) EDI score with more certainty. For example, at ti, when ABP is measured, the confidence interval of the EDI score reduces, but the EDI is still not known with absolute certainty because of the elapsed time since the temperature was measured. It is again noted that although FIGURE 7 shows linear symmetrical confidence interval increases about the last EDI score, this does not necessarily have to be the case. The changes do not have to be linear, or symmetrical in the plus/minus direction.
- the patient monitoring techniques disclosed herein may be embodied by a non-transitory storage medium storing instructions readable and executable by an electronic data processing device (e.g. the patient monitor 20) to perform the disclosed techniques.
- a non-transitory storage medium may, for example, comprise a hard drive or other magnetic storage medium, an optical disk or other optical storage medium, a cloud-based storage medium such as a RAID disk array, flash memory or other non-volatile electronic storage medium, or so forth.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physiology (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Artificial Intelligence (AREA)
- Signal Processing (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Emergency Alarm Devices (AREA)
- Alarm Systems (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017526557A JP6692355B2 (en) | 2014-11-20 | 2015-11-16 | A method for score confidence interval estimation when vital sign sampling frequency is limited |
CN201580062912.4A CN107106024B (en) | 2014-11-20 | 2015-11-16 | Method for fractional confidence interval estimation when vital sign sampling frequency is limited |
US15/525,201 US10456087B2 (en) | 2014-11-20 | 2015-11-16 | Method for score confidence interval estimation when vital sign sampling frequency is limited |
RU2017121610A RU2017121610A (en) | 2014-11-20 | 2015-11-16 | METHOD FOR ASSESSING QUANTITATIVE INDICATORS BY USING THE CONFIDENCE INTERVAL WITH A LIMITED FREQUENCY OF MEASUREMENTS OF LIFE INDICATORS |
EP15801945.5A EP3220802A1 (en) | 2014-11-20 | 2015-11-16 | Method for score confidence interval estimation when vital sign sampling frequency is limited |
BR112017010355A BR112017010355A2 (en) | 2014-11-20 | 2015-11-16 | patient monitoring system and method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462082259P | 2014-11-20 | 2014-11-20 | |
US62/082,259 | 2014-11-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016079654A1 true WO2016079654A1 (en) | 2016-05-26 |
Family
ID=54708087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2015/058847 WO2016079654A1 (en) | 2014-11-20 | 2015-11-16 | Method for score confidence interval estimation when vital sign sampling frequency is limited |
Country Status (7)
Country | Link |
---|---|
US (1) | US10456087B2 (en) |
EP (1) | EP3220802A1 (en) |
JP (1) | JP6692355B2 (en) |
CN (1) | CN107106024B (en) |
BR (1) | BR112017010355A2 (en) |
RU (1) | RU2017121610A (en) |
WO (1) | WO2016079654A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019013094A1 (en) * | 2017-07-14 | 2019-01-17 | 公立大学法人横浜市立大学 | Aggravation estimation device and aggravation estimation program |
WO2019020497A1 (en) * | 2017-07-25 | 2019-01-31 | Koninklijke Philips N.V. | Contextualized patient-specific presentation of prediction score information |
CN114966199A (en) * | 2022-05-12 | 2022-08-30 | 贵州电网有限责任公司 | High-precision rapid calculation method for frequency or rotating speed |
US20220351859A1 (en) * | 2016-05-11 | 2022-11-03 | Tyto Care Ltd. | User interface for navigating through physiological data |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6770521B2 (en) * | 2015-02-12 | 2020-10-14 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Robust classifier |
JP6210519B2 (en) * | 2015-07-10 | 2017-10-11 | パラマウントベッド株式会社 | Patient state determination device and patient state determination method |
US11504071B2 (en) | 2018-04-10 | 2022-11-22 | Hill-Rom Services, Inc. | Patient risk assessment based on data from multiple sources in a healthcare facility |
US11908581B2 (en) | 2018-04-10 | 2024-02-20 | Hill-Rom Services, Inc. | Patient risk assessment based on data from multiple sources in a healthcare facility |
US10980488B2 (en) | 2018-09-20 | 2021-04-20 | Pacific Delta Llc | Determination of blood pressure measurement confidence using variable monitor inaccuracy |
CN111161866B (en) * | 2018-11-07 | 2023-11-17 | 深圳初量科技有限公司 | Identification method with auxiliary identity identification mechanism |
US11694811B2 (en) * | 2019-07-05 | 2023-07-04 | Hill-Rom Services, Inc. | Vital sign monitors for inpatient medicine wards |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080269625A1 (en) * | 2004-02-05 | 2008-10-30 | Earlysense Ltd. | Prediction and monitoring of clinical episodes |
US20100249549A1 (en) * | 2009-03-24 | 2010-09-30 | Nellcor Puritan Bennett Llc | Indicating The Accuracy Of A Physiological Parameter |
WO2014071145A1 (en) * | 2012-11-02 | 2014-05-08 | The University Of Chicago | Patient risk evaluation |
WO2014158133A1 (en) * | 2013-03-25 | 2014-10-02 | Draeger Medical Systems, Inc. | Interface for displaying temporal blood oxygen levels |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000107144A (en) | 1998-10-01 | 2000-04-18 | Nippon Colin Co Ltd | Blood pressure monitoring device |
US6684090B2 (en) * | 1999-01-07 | 2004-01-27 | Masimo Corporation | Pulse oximetry data confidence indicator |
US9247901B2 (en) * | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
JP2004248793A (en) * | 2003-02-19 | 2004-09-09 | Philips Japan Ltd | Bedside information system |
US8852094B2 (en) * | 2006-12-22 | 2014-10-07 | Masimo Corporation | Physiological parameter system |
US20090187082A1 (en) * | 2008-01-21 | 2009-07-23 | Cuddihy Paul E | Systems and methods for diagnosing the cause of trend shifts in home health data |
US20110077484A1 (en) * | 2009-09-30 | 2011-03-31 | Nellcor Puritan Bennett Ireland | Systems And Methods For Identifying Non-Corrupted Signal Segments For Use In Determining Physiological Parameters |
RU2603052C2 (en) | 2011-03-01 | 2016-11-20 | Конинклейке Филипс Н.В. | Patient deterioration detection |
WO2012176162A1 (en) | 2011-06-22 | 2012-12-27 | Koninklijke Philips Electronics N.V. | Mapping of health data |
US9636070B2 (en) * | 2013-03-14 | 2017-05-02 | DePuy Synthes Products, Inc. | Methods, systems, and devices for monitoring and displaying medical parameters for a patient |
US20150018660A1 (en) * | 2013-07-11 | 2015-01-15 | Alivecor, Inc. | Apparatus for Coupling to Computing Devices and Measuring Physiological Data |
-
2015
- 2015-11-16 JP JP2017526557A patent/JP6692355B2/en active Active
- 2015-11-16 BR BR112017010355A patent/BR112017010355A2/en not_active Application Discontinuation
- 2015-11-16 WO PCT/IB2015/058847 patent/WO2016079654A1/en active Application Filing
- 2015-11-16 RU RU2017121610A patent/RU2017121610A/en not_active Application Discontinuation
- 2015-11-16 US US15/525,201 patent/US10456087B2/en active Active
- 2015-11-16 EP EP15801945.5A patent/EP3220802A1/en active Pending
- 2015-11-16 CN CN201580062912.4A patent/CN107106024B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080269625A1 (en) * | 2004-02-05 | 2008-10-30 | Earlysense Ltd. | Prediction and monitoring of clinical episodes |
US20100249549A1 (en) * | 2009-03-24 | 2010-09-30 | Nellcor Puritan Bennett Llc | Indicating The Accuracy Of A Physiological Parameter |
WO2014071145A1 (en) * | 2012-11-02 | 2014-05-08 | The University Of Chicago | Patient risk evaluation |
WO2014158133A1 (en) * | 2013-03-25 | 2014-10-02 | Draeger Medical Systems, Inc. | Interface for displaying temporal blood oxygen levels |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220351859A1 (en) * | 2016-05-11 | 2022-11-03 | Tyto Care Ltd. | User interface for navigating through physiological data |
WO2019013094A1 (en) * | 2017-07-14 | 2019-01-17 | 公立大学法人横浜市立大学 | Aggravation estimation device and aggravation estimation program |
JP2019017998A (en) * | 2017-07-14 | 2019-02-07 | 公立大学法人横浜市立大学 | Severity estimation device and severity estimation program |
JP6993690B2 (en) | 2017-07-14 | 2022-01-13 | 株式会社Cross Sync | Severity estimation device and severity estimation program |
WO2019020497A1 (en) * | 2017-07-25 | 2019-01-31 | Koninklijke Philips N.V. | Contextualized patient-specific presentation of prediction score information |
CN111066091A (en) * | 2017-07-25 | 2020-04-24 | 皇家飞利浦有限公司 | Contextualized patient-specific presentation of predictive scoring information |
US11482334B2 (en) | 2017-07-25 | 2022-10-25 | Koninklijke Philips N.V. | Contextualized patient-specific presentation of prediction score information |
CN114966199A (en) * | 2022-05-12 | 2022-08-30 | 贵州电网有限责任公司 | High-precision rapid calculation method for frequency or rotating speed |
Also Published As
Publication number | Publication date |
---|---|
RU2017121610A (en) | 2018-12-20 |
US10456087B2 (en) | 2019-10-29 |
CN107106024B (en) | 2020-11-20 |
US20170360379A1 (en) | 2017-12-21 |
CN107106024A (en) | 2017-08-29 |
JP2018506759A (en) | 2018-03-08 |
EP3220802A1 (en) | 2017-09-27 |
JP6692355B2 (en) | 2020-05-13 |
BR112017010355A2 (en) | 2017-12-26 |
RU2017121610A3 (en) | 2019-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10456087B2 (en) | Method for score confidence interval estimation when vital sign sampling frequency is limited | |
JP6408479B2 (en) | Patient monitoring system and patient monitoring method | |
US10095838B2 (en) | Graphical presentation of EWS/patient state | |
US10226200B2 (en) | User interface enhancements for physiological parameter monitoring platform devices | |
JP6018623B2 (en) | Staged alarm method for patient monitoring | |
JP6010558B2 (en) | Detection of patient deterioration | |
US20090088606A1 (en) | Systems and methods for patient specific adaptable telemonitoring alerts | |
WO2015187370A1 (en) | Custom early warning scoring for medical device | |
EP3153100A1 (en) | Biological brain age calculation device and calculation method therefor | |
EP2505130B1 (en) | Alarm information processing apparatus and alarm information processing program | |
US11580432B2 (en) | System monitor and method of system monitoring to predict a future state of a system | |
US20200178903A1 (en) | Patient monitoring system and method having severity prediction and visualization for a medical condition | |
US9895111B2 (en) | Alarm notification apparatus, system and method for diagnostic monitoring | |
US9603536B2 (en) | Compact technique for visualization of physiological clinical and bedside device data using fishbone representation for vitals | |
JP7076967B2 (en) | Data processing equipment, data processing method and data processing program | |
US20160220127A1 (en) | Wellness or illness assessment system, method, and computer program product | |
JP2008176473A (en) | Patient condition variation predicting device and patient condition variation-managing system | |
EP3760108A1 (en) | Vital sign monitors for inpatient medicine wards | |
JP7245921B2 (en) | Apparatus and method for QT correction | |
WO2015044859A1 (en) | A methodology for hospitalized patient monitoring and icu risk prediction with a physiologic based early warning system | |
US20220359092A1 (en) | A system and method for triggering an action based on a disease severity or affective state of a subject | |
JP7180259B2 (en) | Biological information analysis device, biological information analysis method, and biological information analysis system | |
JP2002345759A (en) | Biological data diagnostic device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15801945 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15525201 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2017526557 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112017010355 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2017121610 Country of ref document: RU Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2015801945 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 112017010355 Country of ref document: BR Kind code of ref document: A2 Effective date: 20170517 |